Millstone Evans Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5K Sell
778
-84
-10% -$1K 0.01% 586
2026
Q1
$5.16K Sell
862
-830
-49% -$6.25K ﹤0.01% 642
2025
Q4
$12.1K Sell
1,692
-18
-1% -$142 0.01% 529
2025
Q3
$18.3K Sell
1,710
-12
-0.7% -$118 0.01% 463
2025
Q2
$16.7K Hold
1,722
0.01% 467
2025
Q1
$25.6K Sell
1,722
-234
-12% -$3.6K 0.02% 416
2024
Q4
$29.2K Buy
+1,956
New +$31.9K 0.02% 378

Other funds holding OGN

Millstone Evans Group's OGN Position: Q2 2026 in Review

Millstone Evans Group reduced its Organon & Co (OGN) stake by 9.7% in Q2 2026, selling an estimated $1K and leaving 778 shares worth $10.5K. The position accounts for 0.01% of the portfolio, ranked #586.

Millstone Evans Group first reported a position in OGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.2K in Q4 2024. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Millstone Evans Group held 778 shares of Organon & Co worth $10.5K as of Q2 2026.
  • Millstone Evans Group sold 84 Organon & Co shares in Q2 2026, an estimated $1K.
  • Organon & Co made up 0.01% of Millstone Evans Group's portfolio in Q2 2026, its #586 holding.
  • Millstone Evans Group first reported a position in Organon & Co in Q4 2024 and has held it in 7 quarters since.
  • Millstone Evans Group's Organon & Co position peaked at $29.2K in Q4 2024.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.